Norcodeine

Establishing the metabolic profile consistent with legitimate codeine administration requires detection of norcodeine, a minor metabolite of codeine formed through N-demethylation by CYP3A4, alongside codeine and morphine. Laboratory testing applications include pain management compliance monitoring, forensic toxicology investigations where distinguishing codeine use from morphine or heroin use is critical, postmortem toxicology, and clinical toxicology assessments requiring comprehensive opiate metabolite profiling. UTAK’s Pain Management Plus panels contain norcodeine in lyophilized urine matrix at high and low concentration levels, supporting confirmation methods used in clinical and forensic laboratories. Stock and custom QC solutions can incorporate related opiates and their metabolites such as codeine, morphine, hydrocodone, hydromorphone, oxycodone, oxymorphone, and other pain management analytes to address your laboratory’s comprehensive opiate testing and metabolite confirmation requirements.